Posted by: ADMIN on: January 20, 2008
The Genetics Policy Institute (GPI) salutes the researchers of Stemagen, Inc. on their accomplishment of cloning human embryos towards a goal of creating patient-specific embryonic stem cells for human therapeutic use.
“This is a good day for stem cell research. SCNT (therapeutic cloning) is potentially an important first step towards finding cures and may lead to [...]
Recent Comments